Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Paraplegia - Step by step to the goal

IRP Schellenberg Research Prize 2016

    • Neurology
    • News
    • RX
  • 3 minute read

The IRP – International Foundation for Research in Paraplegia, Zurich, has been awarding the CHF 100,000 research prize every two years since 2003. The IRP Schellenberg Research Prize thus honors outstanding researchers in the field of paraplegiology. The awardees are honored for the significance of their scientific contributions and their publications in peer-reviewed journals that have promoted a better understanding of the development of lesions and regenerative processes in the spinal cord. The prize was established in honor of Ulrich Schellenberg, founder of the IFP Foundation, Zurich and co-founder of the IRP Foundation Geneva. Since 2014, the two foundations have merged.

At the IRP PAREvening on June 24, 2016 at the Balgrist Campus, this year’s IRP Schellenberg Research Prize was awarded to Prof. Dr. Martin Schwab, Brain Research Institute, University Zürich and Dept. Health Science and Technology, Zurich, awarded. He studied biology in Basel and began his career at the Biocenter at the University of Basel before going to Harvard Medical School, Boston, and for six years to the Max Planck Institute for Psychiatry, Munich. Since 1985 he has been working at the Brain Research Institute of the University of Zurich and is a professor at ETH Zurich. He is vice president of the IRP Research Council and has been conducting research in spinal cord injury for nearly 30 years and discovered the growth inhibitor Nogo-A.

From laboratory animal to patient

In laboratory animals, success was already achieved twenty years ago when, thanks to the discovery of the growth inhibitor Nogo-A, injured nerve fibers in the spinal cord began to sprout again. In an interview, Prof. Dr. Martin Schwab explains why it took so long for a phase 2 trial with patients to begin this fall: “I also had to learn that the so-called translation of a research result from basic research into clinical application and a new therapy is so long and arduous. On the one hand, the security requirements are very high, which is correct, but costs a lot of time and effort. On the other hand, some preparatory work was also necessary on the clinical side, e.g., improving diagnostics and stratification according to patient severity, standardizing functional measurements, and training physicians and therapists at all participating centers. This was achieved through the European clinical network EMSCI (European Multicenter Study), which we established together with Prof. Armin Curt and his predecessor, Prof. Volker Dietz, from Balgrist University Hospital, Zurich, with substantial financial support from  IRP.”

 

Although Schwab has been retired for two years, he considers it an incredible privilege to continue working on these exciting research questions as a “senior professor.” He especially appreciates the cooperation with the many young, bright and enthusiastic people. So the prize money of CHF 100,000 received is a welcome support so that he and his team can once again take a step forward in their important work. Martin Schwab, along with Ulrich Schellenberg, was one of the co-founders of the IRP and describes the International Foundation for Research in Paraplegia as one of the most important supporters of research in paraplegia worldwide. He hopes the new therapies will help paraplegic patients regain lost spinal cord function and lose their disability.

IRP – International Foundation for Research in Paraplegia
Seestrasse 19, 8002 Zurich
www.irp.ch

Partner
  • irp_logo
Autoren
  • Béatrice Brunner
Publikation
  • HAUSARZT PRAXIS
Related Topics
  • IRP
  • paraplegia
Previous Article
  • HIV and cancer

Why do some tumors occur more frequently under HAART?

  • Allergology and clinical immunology
  • Dermatology and venereology
  • Education
  • Infectiology
  • Oncology
  • RX
View Post
Next Article
  • Mania and depression

Two sides of one coin or two different coins?

  • Psychiatry and psychotherapy
  • RX
  • Studies
View Post
You May Also Like
View Post
  • 10 min
  • Cutaneous lupus erythematosus

From diagnostic workup to successful treatment

    • Congress Reports
    • Dermatology and venereology
    • RX
    • Studies
View Post
  • 4 min
  • Guideline update

Dietary recommendations for Crohn’s disease and colitis

    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Nutrition
    • RX
    • Studies
View Post
  • 4 min
  • Circadian rhythm during Ramadan

Disturbed sleep patterns lead to metabolic stress

    • Education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Nutrition
    • RX
    • Studies
View Post
  • 6 min
  • Case Report

Breast cancer metastases in the bladder

    • Cases
    • Education
    • Gynecology
    • Oncology
    • RX
    • Urology
View Post
  • 11 min
  • Findings from the ALS Symposium 2024 in Montreal

Current and future approaches in the treatment of amyotrophic lateral sclerosis (ALS)

    • Congress Reports
    • Interviews
    • Neurology
    • RX
    • Studies
View Post
  • 8 min
  • Efficacy, mechanism of action and clinical effects

Garlic and high blood pressure

    • Cardiology
    • Education
    • General Internal Medicine
    • Pharmaceutical medicine
    • Phytotherapy
    • RX
    • Studies
View Post
  • 7 min
  • Moderate to severe chronic hand eczema

Delgocitinib cream – first topical pan-JAK inhibitor approved in Switzerland

    • Allergology and clinical immunology
    • Dermatology and venereology
    • Education
    • Infectiology
    • Market & Medicine
    • Pharmacology and toxicology
    • RX
View Post
  • 9 min
  • Wild-type transthyretin amyloid cardiomyopathy (ATTRwt-CA)

Diagnosis at an early stage, prognostic classifications and outlook

    • Cardiology
    • Education
    • RX
    • Studies
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
  • Dermatology News

    Zum Thema
Top CME content
  • 1
    Patience, knowledge and persistence in therapy
  • 2
    Sarcopenia and malnutrition in the context of pneumological rehabilitation
  • 3
    Medical and psychosocial perspectives
  • 4
    New nomenclature for non-alcoholic fatty liver disease
  • 5
    Examinations and considerations before therapy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.